Stock Data
$0.34 (0.90%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
HEALTH INFORMATION SERVICES
Omnicell Inc specializes in providing comprehensive medication management solutions and tools to enhance patient adherence, catering to healthcare systems and pharmacies globally. Their offerings include automation solutions for point of care and central pharmacy operations, such as automated dispensing systems for medications and supplies, robotic systems for efficient medication stocking and retrieval, and IV compounding robots. Additionally, Omnicell delivers software for inventory management and solutions for single-dose medication packaging to support patient-specific needs, aiming to improve clinical workflows and medication adherence across healthcare settings.
Omnicell doubled earnings expectations with $0.94 EPS versus a $0.47 estimate, powered by a $15 million tariff refund and resilient demand for pharmacy automation that lifted non-GAAP EBITDA margin to 21.5% from 13.2% year ago. The company raised full-year profit guidance to $2.15 to $2.30 EPS but trimmed annual recurring revenue guidance as certain growth opportunities develop more slowly than expected.
0 Articles
No articles found for Omnicell.
Our top personal finance-related articles today. Your wallet will thank you later.
